Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.

Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced that ...

Sex‐related differences in Takotsubo syndrome have been described, but no information is available in patients who develop cardiogenic shock. Sex does not affect the prognosis once cardiogenic shock ...

My name is Vakkaleri Nischitha Kumari and I am raising funds for my daughter, B.S Shanvika who is suffering from Refractory cardiogenic shock (RCS) and is undergoing treatment at Star Hospitals, ...

In this paper, we introduce a data processing pipeline for cardiogenic shock (CS) prediction from the MIMIC III database of intensive cardiac care unit patients with acute coronary syndrome. The ...

More information: Suzanne Krais et al, Improving Cardiogenic Shock Team Activation Through Nurse Education and Alert Implementation, Critical Care Nurse (2024). DOI: 10.4037/ccn2024259 Provided by ...

Windtree Therapeutics (WINT) announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a ...

Upon arrival, she was cyanotic, restless, in cardiogenic shock, and had cold extremities with undetectable blood pressure.

Most of the change in stage of cardiogenic shock (CS) occurred within the first 24 hours of presentation, with little change thereafter, according to a study by the Cardiogenic Shock Working Group ...

Implantation of the Impella CP micro-axial flow pump may increase survival at six months among patients with STEMI complicated by cardiogenic shock (CS), according to the results of the DanGer Shock ...